0001564590-20-016124 Sample Contracts

INVESTMENT AGREEMENT
Investment Agreement • April 9th, 2020 • Aravive, Inc. • Pharmaceutical preparations • New York

THIS INVESTMENT AGREEMENT (this “Agreement”) is made and entered into at 3:30 p.m. on April 6, 2020, by and among Eshelman Ventures, LLC, a North Carolina limited liability company (the “Investor”), Aravive, Inc., a Delaware corporation (the “Company”), and, solely for purposes of Article IV and Article V, Fredric N. Eshelman, Pharm.D. (the “Incoming Chairman”).

AutoNDA by SimpleDocs
AGREEMENT
Agreement • April 9th, 2020 • Aravive, Inc. • Pharmaceutical preparations • Delaware

THIS AGREEMENT (the “Agreement”) dated as of April 8, 2020, is between Aravive, Inc., a Delaware corporation (the “Company”), and Robert Hoffman, a non-employee director of the Company (the “Participant”). Capitalized terms used herein without definition shall have the meaning ascribed such terms in the 2014 Equity Incentive Plan and the 2019 Equity Incentive Plan (the “Plans”).

AGREEMENT
Agreement • April 9th, 2020 • Aravive, Inc. • Pharmaceutical preparations • Delaware

THIS AGREEMENT (the “Agreement”) dated as of April 8, 2020, is between Aravive, Inc., a Delaware corporation (the “Company”), and Srinivas Akkaraju, a non-employee director of the Company (the “Participant”). Capitalized terms used herein without definition shall have the meaning ascribed such terms in the 2014 Equity Incentive Plan and the 2019 Equity Incentive Plan (the “Plans”).

SEPARATION AGREEMENT AND RELEASE
Separation Agreement and Release • April 9th, 2020 • Aravive, Inc. • Pharmaceutical preparations • California

This Separation Agreement and Release (“Agreement”) is made by and between Rekha Hemrajani (“Employee”) and Aravive, Inc. (“Aravive”, or the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).

AGREEMENT
Agreement • April 9th, 2020 • Aravive, Inc. • Pharmaceutical preparations • Delaware

THIS AGREEMENT (the “Agreement”) dated as of April 8, 2020, is between Aravive, Inc., a Delaware corporation (the “Company”), and Jay Shepard, a non-employee director of the Company (the “Participant”). Capitalized terms used herein without definition shall have the meaning ascribed such terms in the 2014 Equity Incentive Plan and the 2019 Equity Incentive Plan (the “Plans”).

Time is Money Join Law Insider Premium to draft better contracts faster.